DSIP (delta sleep-inducing peptide) was first isolated from rabbit cerebral venous blood in 1974 and has accumulated a small but published clinical-trial base most notably a 1992 Schneider-Helmert study showing improved sleep with DSIP infusion in chronic insomniacs over 7 successive nights and earlier studies showing improved sleep duration in middle-aged chronic insomniacs
Gut Health Diagnosis at EverVital Nutrition Are you struggling with side effects of GLP-1 meds like Ozempic face (read about what that is here), diarrhea, constipation, cramping, or nausea
A structured plan for life after medication to prevent weight regain Research from the STEP 1 extension trial showed that people who stopped semaglutide regained roughly two-thirds of the weight theyd lost within a year
Why this happens: baseline appetite returns metabolic adaptation lean muscle loss during weight loss long-term GI changes Weight cycling can harm: metabolic health cardiovascular function psychological wellbeing Who Is Most at Risk of Long-Term Side Effects
According to FDA prescribing information, the frequency of side effects varies between Ozempic (for type 2 diabetes) and Wegovy (for weight management), with higher rates typically seen with Wegovy as it is titrated to higher doses
Increased growth hormone and IGF-1 levels are among the most commonly cited benefits and may support cell repair, tissue regeneration, and fat regulation